Airway diseases
Interstitial lung diseases
Pulmonary vascular diseases
Respiratory critical care
Respiratory infections
Thoracic oncology
Thematic poster
Integrated care and non-pharmacological management of COPD
Methods :
General respiratory patient care, Endoscopy and interventional pulmonology, Physiology
Late Breaking Abstract - Qter® and Creatine improve functional performance in COPD patients on long-term oxygen therapy
B. Celli Croquer(Boston, United States)
COI
1
Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis)
L. Fabbri(Modena, Italy)
COI
2
Pre-discharge assessment and outcomes of patients commenced on short-term oxygen therapy
G. Antunes(Saltburn by the sea, United Kingdom)
COI
3
Advance Care Planning in Patients with Chronic Obstructive Pulmonary Disease assessed for Long Term Oxygen Therapy
F. Hildebrand(Coburg (VIC), Australia)
COI
4
Impact of long-term oxygen therapy on systemic inflammation, morphological changes of red blood cells, pulmonary hemodynamics and diaphragm function in patients with chronic obstructive pulmonary disease.
O. Titova(St. Petersburg, Russian Federation)
COI
5
Oxygen alert cards versus Oxygen Alert Wrist Bands (OxyBand) in COPD
E. Rickards(St Helens (Merseyside), United Kingdom)
COI
6
Follow up after end of trial: Evaluation of usage of oxygen-enriched nasal high flow treatment in COPD with chronic hypoxemic respiratory failure
L. Storgaard(Aabybro, Denmark)
COI
7
COPD Management needs Hospital and Community multi-disciplinary teams to work together to optimise patient care.
M. Apps(Brentwood, United Kingdom)
COI
8
Mortality causes in patients with advanced lung disease in long term oxygen therapy
T. Cunha(Uberlandia (MG), Brazil)
COI
9
Improvements in activation for self-management in patients with chronic airway disease via the COPDnet diagnostic trajectory in secondary care; a pilot study.
J. Antons(Molenhoek, Netherlands)
COI
10
Effect of endoscopic lung volume reductions in patients with emphysema – a single center experience
F. Baty(St. Gallen, Switzerland)
COI
11
Telehealth care vs. standard care in COPD – an international randomised controlled trial (interim analysis)
F. Rassouli(Speicher, Switzerland)
COI
12
Effects of an early rehabilitation program in COPD exacerbation, after an hospital discharge, one-year follow-up
F. Gonçalves Dos Santos Carvalho(Barcelona, Spain)
COI
13
The cost-effectiveness of physical activity in the management of COPD patients in the UK
14
A retrospective review of MDT mortality prediction for patients with COPD using The Gold Standard Framework.
P. Marsden(Manchester (Greater Manchester), United Kingdom)
COI
15
BACTERIAL IMMUNOTHERAPY IN COPD AND/OR BRONCHIECTASIS FREQUENT EXACERBATOR PATIENTS. A RETROSPECTIVE STUDY.
J. Belda Ramirez(Valencia, Spain)
COI
16
A simple multifunctional tool for integrated care of COPD
K. Roy(London, United Kingdom)
COI
17
Evaluation of ‘care bundles’ as a means of improving hospital care for patients with acute COPD: a case-study approach
K. Morton(Oxford (Oxfordshire), United Kingdom)
COI
18
Innovating the treatment of COPD exacerbations: a phone tele-system to increase Action Plan adherence
R. Farias(Montréal (QC), Canada)
COI
19
. . .
